Pharmaceuticals

Pediatric Drugs Market Forecast: What to Expect by 2029

November 11, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Pediatric Drugs Market From 2025 To 2034?

The pediatric drugs market size has experienced rapid expansion in recent years. It is projected to grow from $157 billion in 2024 to $179.43 billion in 2025, at a compound annual growth rate (CAGR) of 14.3%. The growth observed in the past can be attributed to factors such as the increasing demand for related medications, a significant pediatric population, greater awareness of pediatric diseases, the expansion of pediatric oncology, the emergence of digital health and telemedicine, and enhanced collaboration in pediatric drug development.

The pediatric drugs market is projected to experience substantial expansion in the coming years. This market is predicted to reach $308.57 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.5%. Factors contributing to this growth during the forecast period include an expanding pediatric population, a growing incidence of pediatric mental health challenges, an increasing count of children suffering from chronic ailments, enhanced vaccination rates among children, and a heightened need for pediatric mental health treatments. Key trends anticipated for this period involve personalized pediatric medicine, the incorporation of technology into pediatric drug delivery, the adoption of telemedicine and digital health innovations, advancements in pediatric clinical trials, and stronger partnerships between pediatricians and pharmacists.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21249&type=smp

Which Drivers Are Shaping The Pediatric Drugs Industry’s Market Share?

The increasing prevalence of preterm births is set to accelerate the expansion of the pediatric drugs market. Preterm births refer to infants born before completing 37 weeks of pregnancy, which is earlier than the typical 40-week gestational period. This rise in preterm deliveries is attributed to factors like advanced maternal age, certain lifestyle choices, various medical conditions, multiple gestations, and inadequate prenatal care. Pediatric drugs are vital for assisting the well-being and development of preterm infants, offering targeted treatments for complications such as respiratory issues, infections, and nutrient deficiencies. For instance, in December 2022, according to the report published by Tommy’s, a UK-based charity organization, in 2022, the percentage of premature live births in England and Wales was 7.9%, up from 7.5% in 2021. This represents over 53,000 babies born prematurely in 2022. Therefore, the escalating number of preterm births is significantly boosting the growth of the pediatric drugs market.

What Are The Major Segment Categories Driving The Pediatric Drugs Market Growth?

The pediatric drugs market covered in this report is segmented –

1) By Type: Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs, Cardiovascular Drugs

2) By Route Of Administration: Oral, Topical, Parenteral, Other Route Of Administrations

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Respiratory Disorder Drugs: Asthma Medications, Cystic Fibrosis Treatments, Bronchodilators, Corticosteroids

2) By Autoimmune Disorder Drugs: Immunosuppressants, Biologic Therapies, Disease-Modifying Antirheumatic Drugs (DMARDs)

3) By Gastrointestinal Drugs: Proton Pump Inhibitors (PPIs), Antiemetics, Antidiarrheals, Laxatives

4) By Cardiovascular Drugs: Antihypertensive Medications, Heart Failure Treatments, Antiarrhythmic Drugs, Lipid-lowering Agents

How Are Trends Influencing The Pediatric Drugs Market?

Key companies within the pediatric drugs market are prioritizing the development of innovative medications, such as fully human monoclonal antibodies, aimed at enhancing treatment efficacy and reducing side effects for young patients. A fully human monoclonal antibody (mAb) is an antibody completely derived from human genetic sequences, thereby minimizing the likelihood of immune system reactions when compared to chimeric or humanized monoclonal antibodies. These antibodies are produced using advanced biotechnology techniques, including transgenic mice with human antibody genes or phage display technology. As an illustration, in August 2022, Johnson and Johnson, a US-based pharmaceutical company, obtained FDA approval for STELARA (ustekinumab) for treating pediatric patients aged six years and older who have active psoriatic arthritis (PsA). This approval signifies a notable breakthrough as STELARA is the initial and sole biologic therapy targeting interleukin-12 (IL-12) and interleukin-23 (IL-23), essential cytokines implicated in inflammatory responses tied to autoimmune diseases. Active PsA is a rare ailment affecting approximately 5-8% of children with chronic inflammatory arthritis, presenting symptoms such as joint swelling and skin lesions.

Who Are The Top Performing Companies In The Pediatric Drugs Market In Recent Years?

Major companies operating in the pediatric drugs market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb, AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Eli Lilly and Co., Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Vertex Pharmaceuticals, UCB Pharma, Sun Pharmaceutical Industries Ltd., Perrigo Company, Shionogi & Co. Ltd., Mallinckrodt, Torrent Pharmaceuticals Ltd, Sarepta Therapeutics, Zydus Cadila

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pediatric-drugs-global-market-report

Which Geographies Are Emerging As Strong Markets For The Pediatric Drugs Industry?

North America was the largest region in the pediatric drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pediatric Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21249&type=smp

Browse Through More Reports Similar to the Global Pediatric Drugs Market 2025, By The Business Research Company

Pediatric Dental Crown Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-dental-crown-global-market-report

Pediatric Imaging Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-imaging-global-market-report

Pediatric Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pediatric-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795